The active substance is ketotifen.
Ketotifen HASCO, syrup is indicated in the prevention of bronchial asthma and symptomatic treatment of allergic rhinitis and allergic conjunctivitis. The product is not effective in the treatment of acute asthma attacks.
Hypersensitivity to the ingredients of the drug.
Co-administration of oral anti-diabetic drugs.
Breast-feeding
Under 7 months of age.
The drug should not be used during pregnancy unless clearly necessary.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl
The active substance is ketotifen.
Ketotifen HASCO, syrup is indicated in the prevention of bronchial asthma and symptomatic treatment of allergic rhinitis and allergic conjunctivitis. The product is not effective in the treatment of acute asthma attacks.
Hypersensitivity to the ingredients of the drug.
Co-administration of oral anti-diabetic drugs.
Breast-feeding
Under 7 months of age.
The drug should not be used during pregnancy unless clearly necessary.
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl